Use of a substance P antagonist for the treatment of pruritus, ocular and/or palpebral pain and ocular or palpebral dysaesthesia

Patent 5730998 Issued on March 24, 1998. Estimated Expiration Date:

December 19, 2015. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Abstract Claims Description Full Text

Patent References

Composition for topical treatment of psoriasis and atopic dermatitis comprising a xanthine derivative Patent #: 5565462
Issued on: 10/15/1996
Inventor: Eitan, et al.

Inventors

Assignee

Societe L'Oreal S.A.

Application

No. 574853 filed on 12/19/1995

US Classes:

424/443, Web, sheet or filament bases; compositions of bandages; or dressings with incorporated medicaments424/423, Surgical implant or material424/451, Capsules (e.g., of gelatin, of chocolate, etc.)424/464Tablets, lozenges, or pills

Examiners

Primary: Azpuru, Carlos

Attorney, Agent or Firm

Burns, Doane, Swecker & Mathis, L.L.P.

Foreign Patent References

93/06099 WO. 04/13/1993

International Classes

A61F 013/02
A61F 002/02
A61K 009/48
A61K 009/20

Foreign Application Priority Data

1994-12-19 FR

Abstract

The invention relates to the use of a substance P antagonist in or for the preparation of a cosmetic or pharmaceutical composition, in particular for topical application, for treating pruritus, ocular or palpebral pain and ocular or palpebral dysaesthesia. The cosmetic composition may be used for making up sensitive eyes or removing make-up therefrom.

Other References

Database WPI, Section Ch, Week 9404, Derwent Publications Ltd., London, GB; Class BO2, AN 94-031791 & JP-A-05,339,240, Dec. 21, 1993
Proceedings of the National Academy of Sciences of USA, vol. 87, No. 12, Jun. 1, 1990, pp. 4833-4835, XP 000134336, Folkers et al, "Spantide II, An . . .